Probenecid-induced membranous nephropathy [5]

Nephrology Dialysis Transplantation

Volumn 22, Issue 8, 2007, Pages 2405-2406

  Izzedine, Hassane ^a   Brocheriou, Isabelle ^a   Becart, Jacques ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; PROBENECID;

AGED; ANAMNESIS; CASE REPORT; CAUCASIAN; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EDEMA; GOUT; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; LETTER; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

AGED; EDEMA; GLOMERULONEPHRITIS, MEMBRANOUS; GOUT; HUMANS; MALE; PROBENECID; PROTEINURIA; URICOSURIC AGENTS;

EID: 34547843582     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl798     Document Type: Letter

References (5)

1. Ferris TF, Morgan WS, Levitin H. Nephrotic syndrome caused by probenecid. N Engl J Med 1961; 265: 381-383
2. Sokol A, Bashner MH, Okun R. Nephrotic syndrome caused by probenecid. JAMA 1967; 199: 43-44
3. Scott JT, O'Brien PK. Probenecid, nephrotic syndrome, and renal failure. Ann Rheum Dis 1968; 27: 249-252
4. Hertz P, Yager H, Richardson JA. Probenecid-induced nephrotic syndrome. Arch Pathol 1972; 94: 241-243
5. Izzedine H, Launay-Vacher V, Bourry E, Brocheriou I, Karie S, Deray G. Drug-induced glomerulopathies. Expert Opin Drug Saf 2006; 5: 95-406